Brazil Scraps Covaxin’s EUA Application After Bharat Biotech Terminates Pact with Partners

Posted on by

Bharat Biotech on July 23 said it terminated the MoU it entered with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its COVID-19 vaccine Covaxin for Brazilian market.